Virtual Medicine Grand Rounds - W. Kimryn Rathmell, PhD, MD presenting: "Genomic Integrity and the TME in ccRCC​."
2021-05-13 12:00 - 13:00 (America/New_York) | WebEx
W. Kimryn Rathmell, PhD, MD

Dr. Kimryn Rathmell is the Chair of Medicine and Physician-in-Chief at Vanderbilt University Medical Center. She is a physician-scientist studying the molecular biology of renal cell carcinomas and rare tumors of the kidney. She earned her undergraduate degrees in Chemistry and Biology at the University of Northern Iowa, and her MD and PhD in Biophysics at Stanford University. She completed internal medicine training at the University of Chicago and the University of Pennsylvania, and fellowship in medical oncology at the University of Pennsylvania. She joined the Departments of Medicine and Genetics at the University of North Carolina in 2003 and was a founding member of the Department of Urology before relocating to Vanderbilt in 2015.
Her research program focuses on understanding the molecular pathogenesis of renal cell carcinomas and spans early models of renal tumorigenesis, novel imaging strategies for diagnosis and screening of kidney cancer, epigenetic regulation of kidney cancers, metabolic features of tumorigenesis, and novel therapeutic strategies to overcome resistance to anti-angiogenic therapy and checkpoint targeted immunotherapy. With these bench to bedside strategies, her laboratory endeavors to integrate knowledge of pathways that promote cancer development with translational clinical studies, and uses these discoveries to develop robust approaches to improve the survival of patients with kidney cancers. She is also deeply committed to the development of physician-scientists. At UNC Chapel Hill, she worked closely with the Medical Scientist Training program, founded the oncology junior faculty mentoring program, and served the Lineberger Comprehensive Cancer Center as Associate Director for Education and Training. At Vanderbilt, she serves as the Deputy Director for Research Integration and Career Development for the Vanderbilt-Ingram Cancer Center. She directs T32 and K12 career development programs, in addition to continuing to serve as a faculty mentor for the Vanderbilt Medical Scientist Training Program. Outside of these activities, she has led organizational initiatives through such work as service on the ASCO Ethics and Education Committees, chaired the ASCO Nominating Committee, founded and served as chair for the Department of Defense Kidney Cancer Research Program, led numerous working groups of the NIH Cancer Genome Atlas (TCGA), served on several editorial boards, most recently the Journal of Clinical Investigation, Cancer Research, and the Journal of Clinical Oncology-Precision Oncology, and served on the ASCI Council as Secretary-Treasurer and President of the Society, leading changes for young physician-scientists, enhancing advocacy and development, and during the founding of the second journal of the society, JCI-Insight. Dr. Rathmell currently serves on the Board of Scientific Advisors for the National Cancer Institute.
